Recent research indicates that the CXCL8/CXCR2 signaling pathway is crucial for the recruitment of myeloid-derived suppressor cells (MDSCs) into the tumor microenvironment (TME), with MDSC accumulation contributing to immune suppression and tumor progression. Here, CXCR2 is linked to neoplasm.